Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/21/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Diane Young

Wrong Dr. Diane Young?

Board of Trustees Member

Phone: (973) ***-****  HQ Phone
The Valerie Fund
2101 Millburn Ave.
Maplewood , New Jersey 07040
United States

Company Description: The Valerie Fund's mission is to provide support for the comprehensive health care of children with cancer and blood disorders.
Background

Employment History

Education

  • MD
  • M.D.
105 Total References
Web References
Board of Trustees
www.thevaleriefund.org, 21 Aug 2014 [cached]
Diane Young, M.D. - Novartis Click here to read biography Diane Young, M.D., Novartis Diane is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she leads a global group of clinical research personnel and oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, and iron chelation therapy. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.
PTCommunity.com - Daily News Briefing
www.pharmscope.com, 5 June 2005 [cached]
"The effectiveness of Gleevec in these five diseases further underscores how cancers and diseases of different origin and location can share common pathways that often respond to the same targeted treatment," said Diane Young, MD, Vice President and global head of Clinical Development at Novartis Oncology.
Board of Trustees - The Valerie Fund
www.thevaleriefund.org, 30 Oct 2009 [cached]
Diane Young, M.D., Novartis
...
Diane Young, M.D., Novartis Diane Young is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, iron chelation therapy, and others. She leads a global group of clinical research personnel. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.
KnoxNews: National
www.knoxnews.net, 10 Mar 2004 [cached]
The drug offers new therapy to about 100,000 each year who complete tamoxifen treatment for breast cancer, said Dr. Diane Young, a Novartis vice president.
FDA Approves Drug for Early Breast Cancer
news.lp.findlaw.com, 11 Mar 2004 [cached]
The drug offers new therapy to about 100,000 each year who complete tamoxifen treatment for breast cancer, said Dr. Diane Young, a Novartis vice president.
Other People with the name "Young":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304